CTRI/2019/04/018434尚未招募3 期
Randomised, Double-Blind, Placebo- Controlled Trial Evaluating Safety and Efficacy of add-on Probiotic in Prevention of Recurrent Urinary Tract Infection in Adult Women
nique Biotech Linited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i.Women of 18-50 years of age who have not attained menopause
- •ii.Women with an active episode of recurrent UTI
- •iii.Recurrent UTI defined as:
- •a)More than 2 symptomatic, culture-proven UTI over past 6 months OR
- •b)More than 3 symptomatic, culture-proven UTI over past 12 months
- •iv.Willing to give informed consent for the study
排除标准
- •i.Polycystic disease, interstitial cystitis, previous urological surgery, stones, or anatomical abnormalities of the urinary tract
- •ii.Pregnant or breastfeeding or planning a pregnancy in the next 6 months
- •iii.Known allergy or intolerance to any of the study products
- •iv.A history of renal stones and/or renal transplantation
- •v.Any immunosuppressive disease or other medical conditions that could potentially interfere with outcomes
- •vi.Current use of corticosteroid, anticoagulant, antidepressants or mood stabilizing medications or other medications that may interact with the supplement
- •vii.Intermittent or indwelling catheterization
研究者
相似试验
已完成
不适用
Randomised, double blind, placebo-controlled, trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1ACharcot-Marie-Tooth disease type 1A (CMT1A)Nervous System DiseasesHereditary and idiopathic neuropathyISRCTN61074476niversity College London (UCL) and University College London Hospitals NHS Trust (UCLH) (UK)50
招募中
3 期
Investigation to assess whether Mi-Gel applied to the vulvar vestibule results in a reduction in pain with intercourse compared to a placeboentry dyspareuniaRenal and Urogenital - Other renal and urogenital disordersNeurological - Other neurological disordersACTRN12619001163190Women's Health & Research Institute of Australia80
终止
3 期
A Study to Compare Loperimide to Placebo for the Prevention of Excess Fluid Losses From the Stoma in Patients with New Loop Ileostomy.ACTRN12614000180617Hunter New England Local Health District86
进行中（未招募）
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-001467-36-PLVifor (International) Inc.650
进行中（未招募）
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyEUCTR2016-001467-36-NLVifor (International) Inc.1,110